Mural Health has launched a non-commercial initiative to share the stories of the people who make clinical research possible. The Portrait Project is a collection of stories detailing the personal experiences of trial participants, caregivers, and medical professionals. The accounts are uncensored and, often, brutally honest. Each story serves to educate by sharing our industry's victories, what is working, where we have fallen short, and opportunities to improve. In all cases, The Portrait Project aims to amplify the voices of patients and their loved-ones.
Headlines involving clinical research often focus on scientific breakthroughs. But behind every groundbreaking innovation are thousands of people—oftentimes critically ill people who are searching for a miracle—who were required to prove the effectiveness of the therapy. Yet, so often, little is known or understood about these people, why they enrolled in the clinical study, and how the trial affected them and their loved ones. The Portrait Project serves to share these often-overlooked narratives, increase awareness, dispel misconceptions, reduce stigmas, and create a community that collectively uses its voice to influence positive change throughout the clinical research ecosystem.
Stories from the Portrait Project cover the spectrum of experiences, from cancer survivors who want to alleviate fears of the newly diagnosed, to caregivers that emotionally recount their journey that ends in the death of a loved one. Certain stories highlight how clinical research profoundly changes lives for the better. Other stories will be critical of the clinical research industry's imperfections, recounting moments of sadness, loss, and personal devastation. As one such contributor comments:
"If you're fortunate enough to survive, what you say has more weight to it. I knew I wanted to use that currency for good. And if I could make the experience less scary for someone, I was willing to be the cancer girl."
Storytellers also offer tips for caregivers, attempting to help others better navigate complex clinical environments while also managing the immense emotional toll charged to patients and their friends and families.
The experience of each participant is unique, but all share a common thread. Each story serves to educate its reader. Ultimately, these stories are intended to have a positive impact on other participants, or help the clinical research industry serve others more effectively.
The Portrait Project is sponsored by Mural Health, a technology company that is on a mission to make it easier to be a participant (a patient or caregiver) in clinical research.
Sam Whitaker, co-founder and co-CEO at Mural Health said: "The Portrait Project has been created because clinical trials are not well understood by the general public and the people who participate are often stereotyped unfairly. Unfortunately, I have also observed these gaps in understanding and stereotyping among my colleagues, the people who should be most in touch with the realities of clinical research. The Portrait Project shares the stories of patients and caregivers so the world, and my colleagues, can get in touch with who these people actually are, why they are involved, and the impact on their caregivers."
The Portrait Project cna be accessed on Instagram, Facebook, LinkedIn, or by visiting its website located at https://portraitproject.muralhealth.com/.
The Portrait Project gives clinical trial patients a platform to share their unique experiences and influence change. (2023, August 1). Cision PR Newswire.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.